Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Clinical trial NCT05554380 · SUSPENDED

Trial details

NCT number: NCT05554380
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Start date: 2023-09-22
Primary completion: 2026-08-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.